Upload
rosalyn-bishop
View
214
Download
0
Tags:
Embed Size (px)
Citation preview
CYT Family Sessions Impact on CYT Process and Outcome
Susan H. Godley, Rodney Funk, Michael L. Dennis, & Mark D. Godley,
Chestnut Health Systems
Acknowledgments
SAMHSA’s Center for Substance Abuse Treatment: (TI11317, TI11320, TI11321, TI11323, TI11324)
CYT colleagues
National Institute on Drug Abuse: RO1 DA 018183
Goals for Presentation
Review CYT study design, process, and outcome findings
Review new analyses that examine predictive relationships among family services and adolescent treatment outcomes
Discuss lessons learned about family-sessions from first wide scale CYT implementation
.
Funded by: The Center for
Substance Abuse Treatment (CSAT)
Substance Abuse and Mental Health
Services Administration (SAMHSA)
U.S. Department of Health & Human Services (DHHS)
CYTCannabis Youth Treatment Experiment: A Collaborative Study of the Effectiveness of Treatment for Cannabis Use Disorders
Sponsored by: Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services
Coordinating Center:Chestnut Health Systems, Bloomington, IL, and Chicago, ILUniversity of Miami, Miami, FLUniversity of Connecticut Health Center, Farmington, CT
Sites:Univ. Conn. Health Center, Farmington, CTOperation PAR, St. Petersburg, FLChestnut Health Systems, Madison County, ILChildren’s Hospital of Phil., Philadelphia, PA
Treatment SeriesC
anna
bis
Yout
h Tr
eatm
ent
Expe
rimen
t
CYT
1. Motivational Enhancement Therapy/Cognitive Behavior Therapy (MET/CBT5)
2. MET/CBT12 (uses Cognitive Behavior Therapy 7 [CBT7] manual)
3. Family Support Network (FSN) –uses MET/CBT5 and 7 manuals PLUS FSN manual
4. Adolescent Community Reinforcement Approach (ACRA)
5. Multidimensional Family Therapy (MDFT)
Treatment SeriesC
anna
bis
Yout
h Tr
eatm
ent
Expe
rimen
t
CYT
1. Motivational Enhancement Therapy/Cognitive Behavior Therapy (MET/CBT5)
2. MET/CBT12 (uses Cognitive Behavior Therapy 7 [CBT7] manual)
3. Family Support Network (FSN) –uses MET/CBT5 and 7 manuals PLUS FSN manual
4. Adolescent Community Reinforcement Approach (ACRA)
5. Multidimensional Family Therapy (MDFT)
Treatment SeriesC
anna
bis
Yout
h Tr
eatm
ent
Expe
rimen
t
CYT
1. Motivational Enhancement Therapy/Cognitive Behavior Therapy (MET/CBT5)
2. MET/CBT12 (uses Cognitive Behavior Therapy 7 [CBT7] manual)
3. Family Support Network (FSN) –uses MET/CBT5 and 7 manuals PLUS FSN manual
4. Adolescent Community Reinforcement Approach (ACRA)
5. Multidimensional Family Therapy (MDFT)
Treatment SeriesC
anna
bis
Yout
h Tr
eatm
ent
Expe
rimen
t
CYT
1. Motivational Enhancement Therapy/Cognitive Behavior Therapy (MET/CBT5)
2. MET/CBT12 (uses Cognitive Behavior Therapy 7 [CBT7] manual)
3. Family Support Network (FSN) –uses MET/CBT5 and 7 manuals PLUS FSN manual
4. Adolescent Community Reinforcement Approach (ACRA)
5. Multidimensional Family Therapy (MDFT)
Treatment SeriesC
anna
bis
Yout
h Tr
eatm
ent
Expe
rimen
t
CYT
1. Motivational Enhancement Therapy/Cognitive Behavior Therapy (MET/CBT5)
2. MET/CBT12 (uses Cognitive Behavior Therapy 7 [CBT7] manual)
3. Family Support Network (FSN) –uses MET/CBT5 and 7 manuals PLUS FSN manual
4. Adolescent Community Reinforcement Approach (ACRA)
5. Multidimensional Family Therapy (MDFT)
Randomly assigned to:
MET/CBT5Motivational Enhancement Therapy/
Cognitive Behavioral Therapy (5 weeks)
MET/CBT12Motivational Enhancement Therapy/
Cognitive Behavioral Therapy (12 weeks)
FSN
Family Support Network
Plus MET/CBT12 (12 weeks)
Trial 1
Two Study Trials
N = 300
ACRAAdolescent Community
Reinforcement Approach(12 weeks)
MDFTMultidimensional Family Therapy
Trial 2
Randomly assigned to:
MET/CBT5Motivational Enhancement Therapy/
Cognitive Behavioral Therapy (5 weeks)
(12 weeks)
N = 300
Design
Inclusion Criteria: 12 to 18 year olds with symptoms of cannabis abuse or dependence, past 90 day use, and meeting criteria for outpatient treatmentData Sources: self report, collateral reports, on-site and laboratory urine testing, therapist alliance and discharge reports, staff service logs, and cost analysis.Intent to Treat AnalysesFollow-up rates were 94% or better at 3, 6, 9, & 12 months post intake
Demographic Characteristics
62%
15%
55%50%
30%
83%
17%
0%
20%
40%
60%
80%
100%
Female Male AfricanAmerican
Caucasian Under
15 to 16 Singleparentfamily
15
Institutional Involvement
25%
87%
47%
62%
0%
20%
40%
60%
80%
100%
In school Employed Current CJInvolvement
Coming fromControlled
Environment
Patterns of Substance Use
9%
17%
71%73%
0%
20%
40%
60%
80%
Weekly Tobacco Use
WeeklyMarijuana Use
Weekly AlcoholUse
Significant Time
in ControlledEnvironment
Multiple Problems are the Norm
86%
37%
12%
25%
61%
60%
66%
83%
83%
0% 20% 40% 60% 80% 100%
Any Marijuana Use Disorder
Any Alcohol Use Disorder
Other Substance Use Disorders
Any Internal Disorder
Any External Disorder
Lifetime History of Victimization
Acts of Physical Violence
Any (other) Illegal Activity
Three to Twelve Problems
Self-Reported in Past Year
Planned Contrast of the Treatment Structures
Individual Adolescent Sessions
CBT Group Sessions
Individual Parent Sessions
Family Sessions/Home Visits
Parent Education Sessions
Total Formal Sessions
Type of ServiceMET/CBT5
MET/CBT12 FSN ACRA MDFT
2
2
2
3 10 10
6
10
6
2 3
4 2 6
5 12 22 14 15
Case management/Other Contacts
As needed
As needed
As needed
Total Expected Contacts 5 12 22+ 14+ 15+
Total Expected Hours
Total Expected Weeks
5 12 22+ 14+ 15+
6-7 12-13 12-13 12-13 12-13
5
10
5
11
14
23
0
5
10
15
20
25
MET/CBT5
MET/CBT12
MET/CBT12 +
FSN
MET/CBT5
ACRA MDFT
Hou
rs
Day
s
CaseManagement
FamilyCounseling
Caregiver only
Multi-Familygroup
Multi-ParticipantGroup
Participant only
Trial 1 Trial 2
Actual Treatment Received by Condition
Source: Dennis et al, 2004
92% engaged
FSN, ACRA and MDFT all include types of family
sessions
CYT Increased Days Abstinent and Percent in Recovery
(no use or problems while in community)
Source: Dennis et al., 2004
0
10
20
30
40
50
60
70
80
90
Intake 3 6 9 12
Day
s A
bsti
nent
Per
Qua
rter
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
% in
Rec
over
y at
the
End
of
the
Qua
rter
Percent in Recovery
Days Abstinent
Similarity of Clinical Outcomes by Conditions
Source: Dennis et al., 2004
200
220
240
260
280
300
Tot
al d
ays
abst
inen
t.
over
12
mon
ths
0%
10%
20%
30%
40%
50%
Per
cent
in R
ecov
ery
.
at M
onth
12
Total Days Abstinent* 269 256 260 251 265 257
Percent in Recovery** 0.28 0.17 0.22 0.23 0.34 0.19
MET/ CBT5 MET/ CBT12
FSN MET/ CBT5 ACRA MDFT
Trial 1 Trial 2
* n.s.d. effect size f=0.06
** n.s.d., effect size f=0.12
* n.s.d., effect size f=0.06 ** n.s.d., effect size f=0.16
Moderate to large differences in Cost-Effectiveness by
Condition
Source: Dennis et al., 2004
$0
$4
$8
$12
$16
$20
Cos
t per
day
of
abst
inen
ce o
ver
12 m
onth
s
$0
$4,000
$8,000
$12,000
$16,000
$20,000
Cos
t per
per
son
in r
ecov
ery
at m
onth
12
CPDA* $4.91 $6.15 $15.13 $9.00 $6.62 $10.38
CPPR** $3,958 $7,377 $15,116 $6,611 $4,460 $11,775
MET/ CBT5MET/
CBT12FSN MET/ CBT5 ACRA MDFT
* p<.05 effect size f=0.48** p<.05, effect size f=0.72
Trial 1 Trial 2
* p<.05 effect size f=0.22
** p<.05, effect size f=0.78
MET/CBT5 and 12 did better
than FSN
ACRA did better than MET/CBT5, and both did better than MDFT
But…3 of the 5 CYT Interventions had some type
of family sessions (ACRA, FSN, MDFT)—what if we look at different types of family
sessions and how they mediate family and
substance abuse outcomes?
Path Model with Services & Other Process Measures
Cohesion
Conflict
RecoveryEnvironment
SocialRisk
SubstanceFrequency
SubstanceProblems
.26
.30 .12
-.14
.27
.14
.49
.18
Baseline ValueFamily
Family
Index
Index
(FES)
(FES)
Source: Godley, Kahn et al., 2005
Risk
Path Model with Services & Other Process Measures
Multi-FamilyCohesion
Conflict
RecoveryEnvironment
SocialRisk
SubstanceFrequency
SubstanceProblems
.26
.30 .12
-.14
.27
.12
.14
.49
.18
Baseline ValueFamily
Hours
Index
Index
(FES)
Family
(FES
Risk
Path Model with Services & Other Process Measures
SingleFamily
Multi-FamilyCohesion
Conflict
SocialSupport
RecoveryEnvironment
SocialRisk
SubstanceFrequency
SubstanceProblems
.26
.30 .12
-.14
.27
.12
.14
TreatmentSatisfaction
ServiceDiversity
.49
.30
.11
.18
-.08
Baseline ValueFamily
Family
Hours
Hours
Index
Index
(FES)
(FES)
.18
Risk
Path Model with Services & Other Process Measures
SocialSupport
RecoveryEnvironment
SocialRisk
SubstanceFrequency
.45
SubstanceProblems
.26
.30 .12
-.14
.27
.12
.14
TreatmentSatisfaction
ServiceDiversity
.49
-.12
.30.18
.11
.18
-.08
Baseline ValueMulti-Family
Hours
CaseManagement
Hours
SingleFamilyHours
Index
Index
ConflictFamily
(FES).14
Cohesion(FES)
Family
Risk
Path Model with Services & Other Process Measures
.15Social
Support
Recovery Environment
SocialRisk
SubstanceFrequency
SubstanceProblems
.26
.30 .12
-.14
.27
.12
.14
TreatmentSatisfaction
ServiceDiversity
.49
-.12
.14
.30
.19
.18
.11
.18
-.08
Baseline ValueMulti-Family
Hours
SingleFamilyHours
Cohesion(FES)
Family
ConflictFamily
(FES)
IndividualHours
CaseManagement
Hours
Risk Index
Index
Path Model with Services & Other Process Measures
Single Family
GroupHours
SocialSupport
RecoveryEnvironment
SocialRisk
SubstanceFrequency
SubstanceProblems
.26
.30 .12
-.14
.27
.12
.14
IndividualHours
TreatmentSatisfaction
ServiceDiversity
.49
-.12
.14
.30
.11
.19
.18
.22 .11
.18
-.08
.10
Baseline ValueMulti-Family
Hours
CaseManagement
Hours
Hours
Cohesion(FES)
Family
ConflictFamily
(FES)
Risk Index
Index
-.08
Path Model with Services & Other Process Measures
Single Family
GroupHours
.27
.23
.15Social
Support
.23Recovery
Environment
.16SocialRisk
.28
SubstanceFrequency
.45
SubstanceProblems
.26
.30 .12
-.14
.27
.12
.14
CaseManagement
IndividualHours
Alliance
.23TreatmentSatisfaction
.19ServiceDiversity
.49
-.12
.10
.14
.30
-.13
.11
.19
.18
.22.11
-.08
.33
.18
-.08
.10
Baseline ValueMulti-Family
Hours
Hours
Hours
Cohesion(FES)
Family
ConflictFamily
(FES)
(WAI)
Risk Index
Index
Path Model with Services & Other Process Measures
Single Family
GroupHours
.27
.23
.15Social
Support
.23Recovery
Environment
.16SocialRisk
.28
SubstanceFrequency
.45
SubstanceProblems
.26
.30 .12
-.14
.27
.12
.14
CaseManagement
IndividualHours
Alliance
.23TreatmentSatisfaction
.19ServiceDiversity
.49
-.12
.10
.14
.30
-.13
.11
.19
.18
.22.11
-.08
.33
.18
-.08
.10
Baseline ValueMulti-Family
Hours
Hours
Hours
Cohesion(FES)
Family
ConflictFamily
(FES)
(WAI)
Index
Risk Index
CFI=.914
RMSEA =.048
And what about implementation of a ‘non-
family’ intervention?In 2003 CSAT initially funded 22 sites to replicate MET/CBT5
A survey of sites early in the field found that 9/15 had added some type of family component (highly variable) See family in home Parent Education Family psychotherapy Family Support
Why?Best practice guidelines say family involvement is critical (Drug Strategies, CSAT Adolescent TIPs)JCAHO expects to see documentation of family participation in assessments, treatment planning, and treatment, when appropriate. Some managed care companies require family participation for reimbursement for servicesClinicians ‘believe in’ the importance of family involvement (Godley et al., 2001)Belief that one can ‘add to’ a manual-guided intervention easier than ‘taking something away’
Conclusions/Recommendations
Family-related factors appear to be predictive of outcome; direct links between family therapies and outcomes are less evidentFamily-related procedures necessary for clinical ‘acceptability’ of an adolescent interventionFindings provide support ‘packages’ of services due to the relation of service diversity to outcomeComparing family to non-family treatment conditions not a relevant question for by the practice communityIncrease research focus on understanding & enhancing effectiveness of the family components of interventions by more directly targeting environmental risk and social support, and evaluate cost-effectiveness
Contact Information
Susan H. Godley, Rh.D.
Chestnut Health Systems
720 W. Chestnut St.
Bloomington, IL 61704
309.829.3543 ext.83343